Compare IDEXX Laboratories, Inc. (IDXX) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? IDEXX Laboratories, Inc. trades at $571.52 (market cap $46.22B), while Invesco S&P 500 High Div Low Volatility ETF trades at $52.47. The key difference: Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | SPHD | |
|---|---|---|
Market Cap | $46.22B | — |
Sector | Health | — |
52-Week High | $766.68 | $53.55 |
52-Week Low | $526.44 | $46.96 |
Enterprise Value | $47.12B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
SPHD trades at $52.405, showing minimal daily movement with a slight decline of 0.01%. The ETF maintains a bullish technical signal from moving averages, while oscillators indicate neutrality. Recent news highlights its focus on high dividends and low volatility, appealing to income investors seeking stability amid market swings. Dividend payments are scheduled for 2026, reinforcing its income-generating strategy.
The outlook for SPHD is stable, supported by its dividend yield and low-volatility approach, attracting retirees and risk-averse investors. Key risks include interest rate sensitivity and broader market downturns, which could impact dividend sustainability and NAV. Analyst sentiment remains positive due to consistent income appeal in volatile environments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
